Cargando…

824. Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience

BACKGROUND: Invasive mucormycosis continues to be associated with high rates of mortality despite advances in management strategies. Recent studies have suggested a benefit to early combination therapy, but overall, the data remain limited regarding its impact on outcomes. METHODS: We conducted a re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Brian, Ha, David R, Shen, Sa, Ferguson, Jessica, Kim, Ailin, Kim, Sarah, Mui, Emily, Deresinski, Stan, Holubar, Marisa, Alegria, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677829/ http://dx.doi.org/10.1093/ofid/ofad500.869

Ejemplares similares

Elimination of Aerosol Ribavirin Use in Immunocompromised Patients with Metapneumovirus and Parainfluenza Virus Infections
por: Mui, Emily, et al.
Publicado: (2017)

Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
por: Fox, Emily, et al.
Publicado: (2022)

1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
por: Marty, Francisco M., et al.
Publicado: (2014)

2532. Identifying Educational Needs and Improving Provider Knowledge Regarding the Management of Febrile Neutropenia
por: Chang, Amy, et al.
Publicado: (2019)

Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center’s Experience
por: Ha, David, et al.
Publicado: (2022)

The Current State of Antifungal Stewardship in Immunocompromised Populations
por: Alegria, William, et al.
Publicado: (2021)

“Acute urinary antibiotics”—A simple metric to identify outpatient antibiotic stewardship opportunities in renal transplant
por: Zimmet, Alex, et al.
Publicado: (2023)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

Mucormycosis: A rare entity with rising clinical presentation in immunocompromised hosts
por: Pandilwar, P.K., et al.
Publicado: (2020)

Invasive Colonic Mucormycosis in an Immunocompromised Postliver Transplant Patient
por: Aggarwal, Pankaj, et al.
Publicado: (2020)

Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit
por: Diep, Calvin, et al.
Publicado: (2021)

Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report
por: Salehi, Mohammadreza, et al.
Publicado: (2020)

Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study
por: Elitzur, Sarah, et al.
Publicado: (2021)

Fatal haemorrhagic duodenal mucormycosis in a non-immunocompromised host: A case report
por: Mungazi, Simbarashe G., et al.
Publicado: (2017)

Cutaneous mucormycosis in the immunocompromised host: An important cause of persistent post traumatic skin lesions
por: Beliavsky, Alina, et al.
Publicado: (2023)

1984. A Multi-Disciplinary Team-based Quality Improvement Initiative to Reduce Clostridioides difficile Rates and Promote Antimicrobial Stewardship in Targeted Surgical Wards
por: Chang, Amy, et al.
Publicado: (2019)

Gastric Mucormycosis: An Infection of Fungal Invasion into the Gastric Mucosa in Immunocompromised Patients
por: Naqvi, Haider A., et al.
Publicado: (2020)

Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia
por: Meng, L, et al.
Publicado: (2021)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

2640. Aerosol vs. Oral Ribavirin for the Treatment of Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients
por: Mui, Emily, et al.
Publicado: (2019)

Electronic phenotyping of community-acquired pneumonia: A tool for inpatient syndrome-specific antimicrobial stewardship
por: Chang, Amy, et al.
Publicado: (2023)

Cutaneous mucormycosis in an immunocompromised patient: a case report
por: Suthananthan, Arul E., et al.
Publicado: (2017)

Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult
por: Sun, George, et al.
Publicado: (2023)

Invasive Mucormycosis Induced Pneumopericardium: A Rare Cause of Pneumopericardium in an Immunocompromised Patient
por: Khan, Sana, et al.
Publicado: (2017)

Molecular Mechanisms of Antifungal Resistance in Mucormycosis
por: Ganesan, Priya, et al.
Publicado: (2022)

A Case of Subcutaneous and Intranasal Phaeohyphomycosis Caused by Microsphaeropsis arundinis in an Immunocompromised Patient Misdiagnosed with Mucormycosis
por: Choi, Hoon, et al.
Publicado: (2019)

Impact of different COVID-19 encounter definitions on antibiotic prescribing rates in urgent care
por: Onguti, Sharon, et al.
Publicado: (2022)

Expanding the genomic encyclopedia of Actinobacteria with 824 isolate reference genomes
por: Seshadri, Rekha, et al.
Publicado: (2022)

Successful management of renal mucormycosis with antifungal therapy and drainage
por: Devana, Sudheer K., et al.
Publicado: (2016)

Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019)

Sporotrichosis In Immunocompromised Hosts
por: Queiroz-Telles, Flavio, et al.
Publicado: (2019)

Infections in the Immunocompromised Host
por: Bin-Hussain, Ibrahim
Publicado: (2012)

Sepsis in Immunocompromised Hosts
por: Conlon, Christopher
Publicado: (2000)

Spontaneous pneumothorax followed by reversed halo sign in immunocompromised patient with pulmonary mucormycosis
por: Moosavi Movahed, Majid, et al.
Publicado: (2015)

Cutaneous Mucormycosis Resulting from Hematogenous Dissemination of Rhizomucor pusillus in an Immunocompromised Patient
por: Menzinger, Sébastien, et al.
Publicado: (2020)

Cutaneous mucormycosis arising in the skin folds of immunocompromised patients: A case series
por: Rrapi, Renajd, et al.
Publicado: (2021)

A Case of Post-COVID-19 Rhino-Cerebral Mucormycosis in an Immunocompromised Patient
por: Faria, Labeeba, et al.
Publicado: (2023)

Comparison of serum PCR assay and histopathology for the diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients with sinus involvement
por: Shokouhi, S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tr6jb6vlfuh2tpkhfqtajsojo0